MAKAYLA CIAVARDONE: Open Payments
NPI 1841974284 · AVON PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,962 in 92 payments from 13 companies in 2025. Trend: 2023 $98 · 2024 $750 · 2025 $1,962
Food & beverage: $1,863Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $368 |
| UCB, Inc. | 24 | $361 |
| AstraZeneca Pharmaceuticals LP | 9 | $281 |
| Amgen Inc. | 12 | $206 |
| Janssen Biotech, Inc. | 4 | $162 |
| PFIZER INC. | 9 | $156 |
| Novartis Pharmaceuticals Corporation | 5 | $149 |
| GlaxoSmithKline, LLC. | 6 | $107 |
| Mallinckrodt Hospital Products Inc. | 3 | $66 |
| Radius Health, Inc. | 2 | $41 |
Products named: Bimzelx, RINVOQ, SAPHNELO, TREMFYA, XELJANZ, COSENTYX, BENLYSTA, SKYRIZI.
Industry payments across FL — which companies pay providers there.
